An experimental Ebola vaccine has been found safe by an early-stage human trial, and it also elicited robust antibody responses in all 40 of the healthy adults who received it. A report describing preliminary results of the study that tested the candidate vaccine called VSV-ZEBOV appeared online in iThe New England Journal of Medicine/i. "The prompt, dose-dependent production of high levels of antibodies following a single injection and the overall ...
http://ift.tt/1FmnseO
http://ift.tt/1BWgEAm
No comments:
Post a Comment